Company page
Immunic, Inc.
Immunic, Inc. is a public company traded under the ticker IMUX in the American market. The company has a market capitalization of approximately $182.4 million. Immunic focuses on developing innovative therapies for autoimmune diseases.
- Ticker
- IMUX:NASDAQ
- Asset type
- Stock
- Market cap
- $210.1M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD